SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-202499
Filing Date
2019-07-25
Accepted
2019-07-25 16:01:33
Documents
3
Period of Report
2019-07-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d780544d8k.htm 8-K 21184
2 EX-3.1 d780544dex31.htm EX-3.1 24346
3 EX-3.2 d780544dex32.htm EX-3.2 122245
  Complete submission text file 0001193125-19-202499.txt   168946
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 19974431
SIC: 2834 Pharmaceutical Preparations